A comprehensive view of hepatitis C management and the goal of eradication
DOI:
https://doi.org/10.59093/27112330.114Keywords:
hepatitis C, direct-acting antivirals.Abstract
Hepatitis C is a viral disease caused by the hepatitis C virus (HCV), which was first identified in 1989 by a team of scientists led by Michael Houghton at Chiron Corporation. This form of hepatitis was known as "non-A non-B hepatitis" as the infectious agent responsible couldn't be identified. It can affect individuals of different genders and sexual orientations, including men who have sex with men (MSM); transmission occurs through situations involving blood exchange, such as needle sharing or equipment for drug injection, or during sexual practices that may cause microlesions in the anal mucosa. It's important to note that hepatitis C can also be transmitted through other routes, such as unsafe blood transfusion, exposure to contaminated medical instruments, or sharing personal items that may have infected blood.
Downloads
References
Campollo O, Amaya G, McCormick PA. Milestones in the discovery of hepatitis C. World J Gastroenterol 2022;28:5395-5402. https://doi.org/10.3748/wjg.v28.i37.5395.
Nijmeijer BM, Koopsen J, Schinkel J, Prins M, Geijtenbeek TB. Sexually transmitted hepatitis C virus infections: Current trends, and recent advances in understanding the spread in men who have sex with men. J Int AIDS Soc 2019;22:e25348. https://doi.org/10.1002/jia2.25348.
Liu CH, Kao JH. Acute hepatitis C virus infection: Clinical update and remaining challenges. Clin Mol Hepatol 2023;29:623-642. https://doi.org/10.3350/cmh.2022.0349.
Lynch EN, Russo FP. Outcomes and follow-up after hepatitis C eradication with direct-acting antivirals. J Clin Med 2023;12:2195. https://doi.org/10.3390/jcm12062195.
Martinello M, Naggie S, Rockstroh JK, Matthews GV. Direct-acting antiviral therapy for treatment of acute and recent hepatitis C virus infection: A narrative review. Clin Infect Dis 2023;77:S238-S244. https://doi.org/10.1093/cid/ciad344.
Daw MA, El-Bouzedi AA, Ahmed MO, Dau AA, Agnan MM, Drah AM. Geographic integration of hepatitis C virus: A global threat. World J Virol 2016;5:170-182. https://doi.org/10.5501/wjv.v5.i4.170.
Parums DV. Effective direct-acting antiviral treatments support global and national programs to eliminate hepatitis C. Med Sci Monit 2023;29:e940519. https://doi.org/10.12659/MSM.940519.
Marín-Zuluaga JI, Díaz-Ramírez GS. Tratamiento actual de la hepatitis C en Colombia. Hepatología 2020;1:99-115. https://doi.org/10.52784/27112330.119.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The authors retain all copyright and grant the Colombian Association of Hepatology a non-exclusive right to publish and disseminate their work.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
